Anstead, G. M., B. Chandrasekar, W. Zhao, J. Yang, L. E. Perez, and P. C. Melby. 2001. Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect. Immun. 69:4709-4718.
Awasthi, A., R. Mathur, A. Khan, B. N. Joshi, N. Jain, S. Sawant, R. Boppana, D. Mitra, and B. Saha. 2003. CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response. J. Exp. Med. 197:1037-1043.
Banville, D., R. Stocco, and S. H. Shen. 1995. Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts. Genomics 27:165-173.
Barr, S. D., and L. Gedamu. 2003. Role of peroxidoxins in Leishmania chagasi survival. Evidence of an enzymatic defense against nitrosative stress. J. Biol. Chem. 278:10816-10823.
Belkaid, Y., B. Butcher, and D. L. Sacks. 1998. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur. J. Immunol. 28:1389-1400.
Belley, A., and K. Chadee. 1995. Eicosanoid production by parasites: from pathogenesis to immunomodulation? Parasitol. Today 11:327-334.
Bertholet, S., H. L. Dickensheets, F. Sheikh, A. A. Gam, R. P. Donnelly, and R. T. Kenney. 2003. Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activation. Infect. Immun. 71:2095-2101.
Bhattacharyya, S., S. Ghosh, P. L. Johnson, S. K. Bhattacharya, and S. Majumdar. 2001. Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events. Infect. Immun. 69:1499-1507.
Bhattacharyya, S., S. Ghosh, P. Sen, S. Roy, and S. Majumdar. 2001. Selective impairment of protein kinase C isotypes in murine macrophage by Leishmania donovani. Mol. Cell. Biochem. 216:47-57.
Blackwell, J. M., R. A. Ezekowitz, M. B. Roberts, J. Y. Channon, R. B. Sim, and S. Gordon. 1985. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J. Exp. Med. 162:324-331.
Blanchette, J., N. Racette, R. Faure, K. A. Siminovitch, and M. Olivier. 1999. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation. Eur. J. Immunol. 29:3737-3744.
Bodman-Smith, K. B., M. Mbuchi, F. J. Culley, P. A. Bates, and J. G. Raynes. 2002. C-reactive protein-mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses. Parasite Immunol. 24:447-454.
Bogdan, C., and M. Rollinghoff. 1998. The immune response to Leishmania: mechanisms of parasite control and evasion. Int. J. Parasitol. 28:121-134.
Bray, R. S., B. Heikal, P. M. Kaye, and M. A. Bray. 1983. The effect of parasitization by Leishmania mexicana mexicana on macrophage function in vitro. Acta Trop. 40:29-38.
Brittingham, A., G. Chen, B. S. McGwire, K. P. Chang, and D. M. Mosser. 1999. Interaction of Leishmania gp63 with cellular receptors for fibronectin. Infect. Immun. 67:4477-4484.
Brittingham, A., C. J. Morrison, W. R. McMaster, B. S. McGwire, K. P. Chang, and D. M. Mosser. 1995. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J. Immunol. 155:3102-3111.
Brooks, D. R., L. Tetley, G. H. Coombs, and J. C. Mottram. 2000. Processing and trafficking of cysteine proteases in Leishmania mexicana. J. Cell Sci. 113:4035-4041.
Buates, S., and G. Matlashewski. 2001. General suppression of macrophage gene expression during Leishmania donovani infection. J. Immunol. 166:3416-3422.
Buchmuller-Rouiller, Y., and J. Mauel. 1987. Impairment of macrophage oxidative-metabolism by Leishmania. Experientia 43:665.
Burshtyn, D. N., W. Yang, T. Yi, and E. O. Long. 1997. A novel phosphotyrosine motif with a critical amino acid at position –2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. J. Biol. Chem. 272:13066-13072.
Callus, B. A., and B. Mathey-Prevot. 1998. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors. Blood 91:3182-3192.
Cameron, P., A. McGachy, M. Anderson, A. Paul, G. H. Coombs, J. C. Mottram, J. Alexander, and R. Plevin. 2004. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-B signaling pathway. J. Immunol. 173:3297-3304.
Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283-289.
Carrera, L., R. T. Gazzinelli, R. Badolato, S. Hieny, W. Muller, R. Kuhn, and D. L. Sacks. 1996. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:515-526.
Chan, J., T. Fujiwara, P. Brennan, M. McNeil, S. J. Turco, J. C. Sibille, M. Snapper, P. Aisen, and B. R. Bloom. 1989. Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc. Natl. Acad. Sci. USA 86:2453-2457.
Chaussabel, D., R. T. Semnani, M. A. McDowell, D. Sacks, A. Sher, and T. B. Nutman. 2003. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 102:672-681.
Chiang, G. G., and B. M. Sefton. 2001. Specific dephosphorylation of the Lck tyrosine protein kinase at Tyr-394 by the SHP-1 protein-tyrosine phosphatase. J. Biol. Chem. 276:23173-23178.
Corradin, S., J. Mauel, A. Ransijn, C. Sturzinger, and G. Vergeres. 1999. Down-regulation of MARCKS-related protein (MRP) in macrophages infected with Leishmania. J. Biol. Chem. 274:16782-16787.
Corradin, S., A. Ransijn, G. Corradin, M. A. Roggero, A. A. Schmitz, P. Schneider, J. Mauel, and G. Vergeres. 1999. MARCKS-related protein (MRP) is a substrate for the Leishmania major surface protease leishmanolysin (gp63). J. Biol. Chem. 274:25411-25418.
Courret, N., E. Prina, E. Mougneau, E. M. Saraiva, D. L. Sacks, N. Glaichenhaus, and J. C. Antoine. 1999. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol. 29:762-773.
Culley, F. J., R. A. Harris, P. M. Kaye, K. P. McAdam, and J. G. Raynes. 1996. C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J. Immunol. 156:4691-4696.
Cunningham, A. C. 2002. Parasitic adaptive mechanisms in infection by leishmania. Exp. Mol. Pathol. 72:132-141.
Das, S., A. K. Saha, A. T. Remaley, R. H. Glew, J. N. Dowling, M. Kajiyoshi, and M. Gottlieb. 1986. Hydrolysis of phosphoproteins and inositol phosphates by cell surface phosphatase of Leishmania donovani. Mol. Biochem. Parasitol. 20:143-153.
David, M., H. E. Chen, S. Goelz, A. C. Larner, and B. G. Neel. 1995. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 15:7050-7058.
De Almeida, M. C., S. A. Cardoso, and M. Barral-Netto. 2003. Leishmania (Leishmania) chagasi infection alters the expression of cell adhesion and costimulatory molecules on human monocyte and macrophage. Int. J. Parasitol. 33:153-162.
Descoteaux, A., and G. Matlashewski. 1989. c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages. Mol. Cell. Biol. 9:5223-5227.
Descoteaux, A., G. Matlashewski, and S. J. Turco. 1992. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J. Immunol. 149:3008-3015.
Descoteaux, A., and S. J. Turco. 1999. Glycoconjugates in Leishmania infectivity. Biochim. Biophys. Acta 1455:341-352.
Desjardins, M., and A. Descoteaux. 1997. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185:2061-2068.
De Souza Leao, S., T. Lang, E. Prina, R. Hellio, and J. C. Antoine. 1995. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J. Cell Sci. 108:3219-3231.
Eilam, Y., J. El On, and D. T. Spira. 1985. Leishmania major: excreted factor, calcium ions, and the survival of amastigotes. Exp. Parasitol. 59:161-168.
Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya, and A. Yoshimura. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924.
Farrell, J. P., and C. E. Kirkpatrick. 1987. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J. Immunol. 138:902-907.
Feng, G. J., H. S. Goodridge, M. M. Harnett, X. Q. Wei, A. V. Nikolaev, A. P. Higson, and F. Y. Liew. 1999. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J. Immunol. 163:6403-6412.
Ferguson, M. A. 1997. The surface glycoconjugates of trypanosomatid parasites. Philos. Trans. R. Soc. London B 352:1295-1302.
Forget, G., K. A. Siminovitch, S. Brochu, S. Rivest, D. Radzioch, and M. Olivier. 2001. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur. J. Immunol. 31:3185-3196.
Frankenburg, S., V. Leibovici, N. Mansbach, S. J. Turco, and G. Rosen. 1990. Effect of glycolipids of Leishmania parasites on human monocyte activity. Inhibition by lipophosphoglycan. J. Immunol. 145:4284-4289.
Frearson, J. A., and D. R. Alexander. 1997. The role of phosphotyrosine phosphatases in haematopoietic cell signal transduction. Bioessays 19:417-427.
Freitas Balanco, J. M., M. E. Moreira, A. Bonomo, P. T. Bozza, G. Amarante-Mendes, C. Pirmez, and M. A. Barcinski. 2001. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr. Biol. 11:1870-1873.
Fruth, U., N. Solioz, and J. A. Louis. 1993. Leishmania major interferes with antigen presentation by infected macrophages. J. Immunol. 150:1857-1864.
Gantt, K. R., S. Schultz-Cherry, N. Rodriguez, S. M. Jeronimo, E. T. Nascimento, T. L. Goldman, T. J. Recker, M. A. Miller, and M. E. Wilson. 2003. Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages. J. Immunol. 170:2613-2620.
Ghosh, S., S. Bhattacharyya, S. Das, S. Raha, N. Maulik, D. K. Das, S. Roy, and S. Majumdar. 2001. Generation of ceramide in murine macrophages infected with Leishmania donovani alters macrophage signaling events and aids intracellular parasitic survival. Mol. Cell. Biochem. 223:47-60.
Ghosh, S., S. Bhattacharyya, M. Sirkar, G. S. Sa, T. Das, D. Majumdar, S. Roy, and S. Majumdar. 2002. Leishmania donovani suppresses activated protein 1 and NF-B activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase. Infect. Immun. 70:6828-6838.
Ghosh, S., S. Goswami, and S. Adhya. 2003. Role of superoxide dismutase in survival of Leishmania within the macrophage. Biochem. J. 369:447-452.
Glickman, M. H., and A. Ciechanover. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82:373-428.
Greenhalgh, C. J., and D. J. Hilton. 2001. Negative regulation of cytokine signaling. J. Leukoc. Biol. 70:348-356.
Guy, R. A., and M. Belosevic. 1993. Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Infect. Immun. 61:1553-1558.
Haque, S. J., P. Harbor, M. Tabrizi, T. Yi, and B. R. Williams. 1998. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J. Biol. Chem. 273:33893-33896.
Haspel, R. L., M. Salditt-Georgieff, and J. E. Darnell, Jr. 1996. The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J. 15:6262-6268.
Hatzigeorgiou, D. E., J. Geng, B. Zhu, Y. Zhang, K. Liu, W. N. Rom, M. J. Fenton, S. J. Turco, and J. L. Ho. 1996. Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequence. Proc. Natl. Acad. Sci. USA 93:14708-14713.
Hawn, T. R., A. Ozinsky, D. M. Underhill, F. S. Buckner, S. Akira, and A. Aderem. 2002. Leishmania major activates IL-1 alpha expression in macrophages through a MyD88-dependent pathway. Microbes Infect. 4:763-771.
Heinzel, F. P., R. M. Rerko, and A. M. Hujer. 1998. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity. Cell. Immunol. 184:129-142.
Hermoso, T., Z. Fishelson, S. I. Becker, K. Hirschberg, and C. L. Jaffe. 1991. Leishmanial protein kinases phosphorylate components of the complement system. EMBO J. 10:4061-4067.
Herwaldt, B. L. 1999. Leishmaniasis. Lancet 354:1191-1199.
Hilton, D. J., R. T. Richardson, W. S. Alexander, E. M. Viney, T. A. Willson, N. S. Sprigg, R. Starr, S. E. Nicholson, D. Metcalf, and N. A. Nicola. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95:114-119.
Holm, A., K. Tejle, T. Gunnarsson, K. E. Magnusson, A. Descoteaux, and B. Rasmusson. 2003. Role of protein kinase C alpha for uptake of unopsonized prey and phagosomal maturation in macrophages. Biochem. Biophys. Res. Commun. 302:653-658.
Holm, A., K. Tejle, K. E. Magnusson, A. Descoteaux, and B. Rasmusson. 2001. Leishmania donovani lipophosphoglycan causes periphagosomal actin accumulation: correlation with impaired translocation of PKCalpha and defective phagosome maturation. Cell Microbiol. 3:439-447.
Huber, M., E. Timms, T. W. Mak, M. Rollinghoff, and M. Lohoff. 1998. Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect. Immun. 66:3968-3970.
Ilg, T., M. Fuchs, V. Gnau, M. Wolfram, D. Harbecke, and P. Overath. 1994. Distribution of parasite cysteine proteinases in lesions of mice infected with Leishmania mexicana amastigotes. Mol. Biochem. Parasitol. 67:193-203.
Joshi, P. B., D. L. Sacks, G. Modi, and W. R. McMaster. 1998. Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63). Mol. Microbiol. 27:519-530.
Junghae, M., and J. G. Raynes. 2002. Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Infect. Immun. 70:5026-5035.
Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275-281.
Kane, M. M., and D. M. Mosser. 2000. Leishmania parasites and their ploys to disrupt macrophage activation. Curr. Opin. Hematol. 7:26-31.
Kaye, P. M., and G. J. Bancroft. 1992. Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect. Immun. 60:4335-4342.
Kaye, P. M., N. J. Rogers, A. J. Curry, and J. C. Scott. 1994. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. Eur. J. Immunol. 24:2850-2854.
Khaled, A. R., E. J. Butfiloski, E. S. Sobel, and J. Schiffenbauer. 1998. Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B. Cell. Immunol. 185:49-58.
Kile, B. T., N. A. Nicola, and W. S. Alexander. 2001. Negative regulators of cytokine signaling. Int. J. Hematol. 73:292-298.
Kima, P. E., N. H. Ruddle, and D. McMahon-Pratt. 1997. Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells. J. Immunol. 159:1828-1834.
Kima, P. E., L. Soong, C. Chicharro, N. H. Ruddle, and D. McMahon-Pratt. 1996. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells. Eur. J. Immunol. 26:3163-3169.
Kirkpatrick, C. E., J. P. Farrell, J. F. Warner, and Denner G. 1985. Participation of natural killer cells in the recovery of mice from visceral leishmaniasis. Cell. Immunol 92:163-171.
Klingmuller, U., U. Lorenz, L. C. Cantley, B. G. Neel, and H. F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729-738.
Krautwald, S., D. Buscher, V. Kummer, S. Buder, and M. Baccarini. 1996. Involvement of the protein tyrosine phosphatase SHP-1 in Ras-mediated activation of the mitogen-activated protein kinase pathway. Mol. Cell. Biol. 16:5955-5963.
Kwan, W. C., W. R. McMaster, N. Wong, and N. E. Reiner. 1992. Inhibition of expression of major histocompatibility complex class II molecules in macrophages infected with Leishmania donovani occurs at the level of gene transcription via a cyclic AMP-independent mechanism. Infect. Immun. 60:2115-2120.
Lang, T., C. de Chastellier, C. Frehel, R. Hellio, P. Metezeau, S. S. Leao, and J. C. Antoine. 1994. Distribution of MHC class I and of MHC class II molecules in macrophages infected with Leishmania amazonensis. J. Cell Sci. 107:69-82.
Lang, T., R. Hellio, P. M. Kaye, and J. C. Antoine. 1994. Leishmania donovani-infected macrophages: characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation. J. Cell Sci. 107:2137-2150.
Liew, F. Y., S. Millott, C. Parkinson, R. M. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797.
Lima, G. M., A. L. Vallochi, U. R. Silva, E. M. Bevilacqua, M. M. Kiffer, and I. A. Abrahamsohn. 1998. The role of polymorphonuclear leukocytes in the resistance to cutaneous leishmaniasis. Immunol. Lett. 64:145-151.
Locksley, R. M., S. L. Reiner, F. Hatam, D. R. Littman, and N. Killeen. 1993. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261:1448-1451.
Lovelace, J. K., D. M. Dwyer, and M. Gottlieb. 1986. Purification and characterization of the extracellular acid phosphatase of Leishmania donovani. Mol. Biochem. Parasitol. 20:243-251.
Maasho, K., F. Sanchez, E. Schurr, A. Hailu, and H. Akuffo. 1998. Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity. Infect. Immun. 66:2698-2704.
Mansfield, J. M., and M. Olivier. 2002. Immune evasion by parasites, p. 379-392. In S. H. E. Kaufmann, A. Sher, and R. Ahmed (ed.), Immunology of infectious diseases. ASM Press, Washington, D.C.
Marrero, M. B., V. J. Venema, H. Ju, D. C. Eaton, and R. C. Venema. 1998. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. Am. J. Physiol. 275:C1216-C1223.
Marth, T., and B. L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185:1987-1995.
Martiny, A., J. R. Meyer-Fernandes, W. de Souza, and M. A. Vannier-Santos. 1999. Altered tyrosine phosphorylation of ERK1 MAP kinase and other macrophage molecules caused by Leishmania amastigotes. Mol. Biochem. Parasitol. 102:1-12.
Massa, P. T., and C. Wu. 1998. Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. J. Interferon Cytokine Res. 18:499-507.
Masuhara, M., H. Sakamoto, A. Matsumoto, R. Suzuki, H. Yasukawa, K. Mitsui, T. Wakioka, S. Tanimura, A. Sasaki, H. Misawa, M. Yokouchi, M. Ohtsubo, and A. Yoshimura. 1997. Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239:439-446.
Matsumoto, A., M. Masuhara, K. Mitsui, M. Yokouchi, M. Ohtsubo, H. Misawa, A. Miyajima, and A. Yoshimura. 1997. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89:3148-3154.
Matte, C., G. Maion, W. Mourad, and M. Olivier. 2001. Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis. Parasite Immunol. 23:177-184.
Matte, C., J. F. Marquis, J. Blanchette, P. Gros, R. Faure, B. I. Posner, and M. Olivier. 2000. Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide. Eur. J. Immunol. 30:2555-2564.
McConville, M. J., and J. M. Blackwell. 1991. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J. Biol. Chem. 266:15170-15179.
McConville, M. J., and J. E. Ralton. 1997. Developmentally regulated changes in the cell surface architecture of Leishmania parasites. Behring Inst. Mitt. 1997:34-43.
McConville, M. J., L. F. Schnur, C. Jaffe, and P. Schneider. 1995. Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species. Biochem. J. 310:807-818.
McConville, M. J., S. J. Turco, M. A. J. Ferguson, and D. L. Sacks. 1992. Developmental modification of lipophosphoglycan during the differentiation of Leishmania-major promastigotes to an infectious stage. EMBO J. 11:3593-3600.
McMaster, W. R., C. J. Morrison, M. H. Macdonald, and P. B. Joshi. 1994. Mutational and functional analysis of the Leishmania surface metalloproteinase GP63: similarities to matrix metalloproteinases. Parasitology 108(Suppl.):S29-S36.
McNeely, T. B., G. Rosen, M. V. Londner, and S. J. Turco. 1989. Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania. Biochem. J. 259:601-604.
McNeely, T. B., and S. J. Turco. 1987. Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan. Biochem. Biophys. Res. Commun. 148:653-657.
Miao, L., A. Stafford, S. Nir, S. J. Turco, T. D. Flanagan, and R. M. Epand. 1995. Potent inhibition of viral fusion by the lipophosphoglycan of Leishmania donovani. Biochemistry 34:4676-4683.
Mosser, D. M., and P. J. Edelson. 1987. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature 327:329-331.
Mottram, J. C., G. H. Coombs, and J. Alexander. 2004. Cysteine peptidases as virulence factors of Leishmania. Curr. Opin. Microbiol. 7:375-381.
Murray, H. W. 1982. Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. J. Immunol. 129:351-357.
Murray, H. W., and C. F. Nathan. 1999. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 189:741-746.
Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and T. Kishimoto. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924-929.
Nandan, D., R. Lo, and N. E. Reiner. 1999. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect. Immun. 67:4055-4063.
Nandan, D., and N. E. Reiner. 1995. Attenuation of gamma-interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect. Immun. 63:4495-4500.
Nandan, D., T. L. Yi, M. Lopez, C. Lai, and N. E. Reiner. 2002. Leishmania EF-1 alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J. Biol. Chem. 277:50190-50197.
Olivier, M. 1996. Modulation of host cell intracellular Ca2+. Parasitol. Today 12:145-150.
Olivier, M., K. G. Baimbridge, and N. E. Reiner. 1992. Stimulus-response coupling in monocytes infected with Leishmania—attenuation of calcium transients is related to defective agonist-induced accumulation of inositol phosphates. J. Immunol. 148:1188-1196.
Olivier, M., R. W. Brownsey, and N. E. Reiner. 1992. Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein-kinase-c. Proc. Natl. Acad. Sci. USA 89:7481-7485.
Olivier, M., B. J. Romero-Gallo, C. Matte, J. Blanchette, B. I. Posner, M. J. Tremblay, and R. Faure. 1998. Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine leishmaniasis progression. J. Biol. Chem. 273:13944-13949.
Olivier, M., and C. E. Tanner. 1987. Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani. Infect. Immun. 55:467-471.
Pawson, T. 1995. Protein modules and signalling networks. Nature 373:573-580.
Piedrafita, D., L. Proudfoot, A. V. Nikolaev, D. M. Xu, W. Sands, G. J. Feng, E. Thomas, J. Brewer, M. A. J. Ferguson, J. Alexander, and F. Y. Liew. 1999. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur. J. Immunol. 29:235-244.
Pimenta, P. F., E. M. Saraiva, and D. L. Sacks. 1991. The comparative fine structure and surface glycoconjugate expression of three life stages of Leishmania major. Exp. Parasitol. 72:191-204.
Prina, E., C. Jouanne, L. S. de Souza, A. Szabo, J. G. Guillet, and J. C. Antoine. 1993. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J. Immunol. 151:2050-2061.
Prive, C., and A. Descoteaux. 2000. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur. J. Immunol. 30:2235-2244.
Proudfoot, L., A. V. Nikolaev, G. J. Feng, W. Q. Wei, M. A. Ferguson, J. S. Brimacombe, and F. Y. Liew. 1996. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl. Acad. Sci. USA 93:10984-10989.
Proudfoot, L., C. A. O'Donnell, and F. Y. Liew. 1995. Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur. J. Immunol. 25:745-750.
Puentes, S. M., D. M. Dwyer, P. A. Bates, and K. A. Joiner. 1989. Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum. J. Immunol. 143:3743-3749.
Ram, P. A., and D. J. Waxman. 1997. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J. Biol. Chem. 272:17694-17702.
Ray, M., A. A. Gam, R. A. Boykins, and R. T. Kenney. 2000. Inhibition of interferon-gamma signaling by Leishmania donovani. J. Infect. Dis. 181:1121-1128.
Reiner, N. E., and C. J. Malemud. 1984. Arachidonic acid metabolism in murine leishmaniasis (Donovani): ex-vivo evidence for increased cyclooxygenase and 5-lipoxygenase activity in spleen cells. Cell. Immunol. 88:501-510.
Reiner, N. E., and C. J. Malemud. 1985. Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways. J. Immunol. 134:556-563.
Reiner, N. E., W. Ng, T. Ma, and W. R. McMaster. 1988. Kinetics of gamma interferon binding and induction of major histocompatibility complex class II mRNA in Leishmania-infected macrophages. Proc. Natl. Acad. Sci. USA 85:4330-4334.
Reiner, N. E., W. Ng, and W. R. McMaster. 1987. Parasite-accessory cell-interactions in murine leishmaniasis. 2. Leishmania donovani suppresses macrophage expression of class-I and class-Ii major histocompatibility complex gene-products. J. Immunol. 138:1926-1932.
Reiner, N. E., W. Ng, C. B. Wilson, W. R. McMaster, and S. K. Burchett. 1990. Modulation of invitro monocyte cytokine responses to Leishmania donovani—interferon-gamma prevents parasite-induced inhibition of interleukin-1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin-1. J. Clin. Investig. 85:1914-1924.
Rodriguez, N. E., H. K. Chang, and M. E. Wilson. 2004. Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi. Infect. Immun. 72:2111-2122.
Saha, B., G. Das, H. Vohra, N. K. Ganguly, and G. C. Mishra. 1995. Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity. Eur. J. Immunol. 25:2492-2498.
Satoskar, A. R., L. M. Stamm, X. Zhang, A. A. Satoskar, M. Okano, C. Terhorst, J. R. David, and B. Wang. 1999. Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection. J. Immunol. 162:6747-6754.
Scharton, T. M., and P. Scott. 1993. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567-577.
Scharton-Kersten, T., L. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-5330.
Schneider, P., J. P. Rosat, J. Bouvier, J. Louis, and C. Bordier. 1992. Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages. Exp. Parasitol. 75:196-206.
Scianimanico, S., M. Desrosiers, J. F. Dermine, S. Meresse, A. Descoteaux, and M. Desjardins. 1999. Impaired recruitment of the small GTPase rab7 correlates with the inhibition of phagosome maturation by Leishmania donovani promastigotes. Cell Microbiol. 1:19-32.
Seay, M. B., P. L. Heard, and G. Chaudhuri. 1996. Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes. Infect. Immun. 64:5129-5137.
Somani, A. K., J. S. Bignon, G. B. Mills, K. A. Siminovitch, and D. R. Branch. 1997. Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. J. Biol. Chem. 272:21113-21119.
Somanna, A., V. Mundodi, and L. Gedamu. 2002. Functional analysis of cathepsin B-like cysteine proteases from Leishmania donovani complex. Evidence for the activation of latent transforming growth factor beta. J. Biol. Chem. 277:25305-25312.
Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, and R. J. Lechleider. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263-273.
Sorensen, A. L., A. S. Hey, and A. Kharazmi. 1994. Leishmania major surface protease Gp63 interferes with the function of human monocytes and neutrophils in vitro. APMIS 102:265-271.
Starr, R., D. Metcalf, A. G. Elefanty, M. Brysha, T. A. Willson, N. A. Nicola, D. J. Hilton, and W. S. Alexander. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95:14395-14399.
Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921.
Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783-793.
Sutterwala, F. S., G. J. Noel, R. Clynes, and D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185:1977-1985.
Sutterwala, F. S., G. J. Noel, P. Salgame, and D. M. Mosser. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J. Exp. Med. 188:217-222.
Suzuki, E., A. K. Tanaka, M. S. Toledo, H. K. Takahashi, and A. H. Straus. 2002. Role of ß-D-galactofuranose in Leishmania major macrophage invasion. Infect. Immun. 70:6592-6596.
Talamas-Rohana, P., S. D. Wright, M. R. Lennartz, and D. G. Russell. 1990. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins. J. Immunol. 144:4817-4824.
Tejle, K., K. E. Magnusson, and B. Rasmusson. 2002. Phagocytosis and phagosome maturation are regulated by calcium in J774 macrophages interacting with unopsonized prey. Biosci. Rep. 22:529-540.
Tripathi, A., and C. M. Gupta. 2003. Transbilayer translocation of membrane phosphatidylserine and its role in macrophage invasion in Leishmania promastigotes. Mol. Biochem. Parasitol. 128:1-9.
Uzonna, J. E., K. L. Joyce, and P. Scott. 2004. Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon -producing CD8+ T cells. J. Exp. Med. 199:1559-1566.
Verdier, F., S. Chretien, O. Muller, P. Varlet, A. Yoshimura, S. Gisselbrecht, C. Lacombe, and P. Mayeux. 1998. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein. J. Biol. Chem. 273:28185-28190.
Verdier, F., P. Walrafen, N. Hubert, S. Chretien, S. Gisselbrecht, C. Lacombe, and P. Mayeux. 2000. Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors. J. Biol. Chem. 275:18375-18381.
Wakil, A. E., Z. E. Wang, J. C. Ryan, D. J. Fowell, and R. M. Locksley. 1998. Interferon gamma derived from CD4+ T cells is sufficient to mediate T helper cell type 1 development. J. Exp. Med. 188:1651-1656.
Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.
Weinheber, N., M. Wolfram, D. Harbecke, and T. Aebischer. 1998. Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur. J. Immunol. 28:2467-2477.
World Health Organisation. 2002. The leishmaniases and Leishmania/HIV co-infections. http://www.who.int/mediacentre/factsheets/fs116/en/.
Xie, Z. H., J. Zhang, and R. P. Siraganian. 2000. Positive regulation of c-Jun N-terminal kinase and TNF-alpha production but not histamine release by SHP-1 in RBL-2H3 mast cells. J. Immunol. 164:1521-1528.
Yeung, Y. G., Y. Wang, D. B. Einstein, P. S. Lee, and E. R. Stanley. 1998. Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages. J. Biol. Chem. 273:17128-17137.
Yi, T. L., J. L. Cleveland, and J. N. Ihle. 1992. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol. Cell. Biol. 12:836-846.
Yoshimura, A., T. Ohkubo, T. Kiguchi, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, T. Hara, and A. Miyajima. 1995. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14:2816-2826.
Yu, C. L., and S. J. Burakoff. 1997. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation. J. Biol. Chem. 272:14017-14020.
Answers to all your Biology Questions
